Trial Profile
A clinical study of DNA-Encoded Monoclonal Antibody (dMAb™) Platform of an infectious disease treatment
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2018
Price :
$35
*
At a glance
- Drugs Anti-infectives (Primary)
- Indications Infections
- Focus Adverse reactions
- 07 Dec 2018 New trial record
- 26 Nov 2018 According to an Inovio Pharmaceuticals media release, the company plans to initiate this trial early next year.